AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
AMZN   2,421.86 (-0.62%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
BAC   24.28 (+7.15%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
AMZN   2,421.86 (-0.62%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
BAC   24.28 (+7.15%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
AMZN   2,421.86 (-0.62%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
BAC   24.28 (+7.15%)
AAPL   316.73 (-0.68%)
MSFT   181.57 (-1.06%)
FB   232.20 (-1.15%)
AMZN   2,421.86 (-0.62%)
BABA   201.72 (+1.01%)
MU   45.80 (+1.91%)
GE   6.80 (+6.08%)
TSLA   818.87 (+0.24%)
ACB   15.61 (-2.50%)
F   5.84 (+3.36%)
GILD   73.18 (-0.22%)
BAC   24.28 (+7.15%)
Log in

NASDAQ:INOVInovalon Stock Price, Forecast & News

$18.90
-0.10 (-0.53 %)
(As of 05/26/2020 04:00 PM ET)
Add
Compare
Today's Range
$18.85
Now: $18.90
$19.46
50-Day Range
$15.58
MA: $16.83
$18.65
52-Week Range
$13.39
Now: $18.90
$22.99
Volume31,217 shs
Average Volume554,072 shs
Market Capitalization$2.94 billion
P/E Ratio210.02
Dividend YieldN/A
Beta0.66
Inovalon Holdings, Inc., a technology company, provides cloud-based platforms empowering data-driven healthcare. It operates the Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 964,000 physicians; 519,000 clinical facilities; and approximately 264 million individuals and 42 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.
Read More
Inovalon logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.36 out of 5 stars


Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:INOV
CUSIPN/A
Phone301-809-4000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$642.41 million
Cash Flow$1.14 per share
Book Value$4.44 per share

Profitability

Net Income$7.78 million

Miscellaneous

Employees2,662
Market Cap$2.94 billion
Next Earnings Date7/29/2020 (Estimated)
OptionableOptionable

Receive INOV News and Ratings via Email

Sign-up to receive the latest news and ratings for INOV and its competitors with MarketBeat's FREE daily newsletter.

Inovalon (NASDAQ:INOV) Frequently Asked Questions

How has Inovalon's stock been impacted by COVID-19 (Coronavirus)?

Inovalon's stock was trading at $17.36 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, INOV shares have increased by 8.9% and is now trading at $18.90. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Inovalon?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last year. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Inovalon.

When is Inovalon's next earnings date?

Inovalon is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Inovalon.

How were Inovalon's earnings last quarter?

Inovalon Holdings Inc (NASDAQ:INOV) issued its quarterly earnings data on Wednesday, April, 29th. The technology company reported $0.11 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.11. The technology company had revenue of $154.19 million for the quarter, compared to analyst estimates of $158.97 million. Inovalon had a return on equity of 9.17% and a net margin of 2.14%. Inovalon's quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.10 earnings per share. View Inovalon's earnings history.

What guidance has Inovalon issued on next quarter's earnings?

Inovalon updated its FY20 earnings guidance on Wednesday, April, 29th. The company provided earnings per share (EPS) guidance of $0.53-0.57 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.56. The company issued revenue guidance of $672-698 million, compared to the consensus revenue estimate of $697.73 million.

What price target have analysts set for INOV?

8 brokers have issued 1 year price objectives for Inovalon's shares. Their forecasts range from $12.00 to $23.00. On average, they expect Inovalon's share price to reach $19.22 in the next year. This suggests a possible upside of 1.7% from the stock's current price. View analysts' price targets for Inovalon.

Has Inovalon been receiving favorable news coverage?

News coverage about INOV stock has been trending extremely negative recently, InfoTrie reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Inovalon earned a daily sentiment score of -5.0 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutInovalon.

Who are some of Inovalon's key competitors?

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Alibaba Group (BABA), NVIDIA (NVDA), Paypal (PYPL), Digital Turbine (APPS), Netflix (NFLX), Verizon Communications (VZ), Ford Motor (F), General Electric (GE), Ollie's Bargain Outlet (OLLI) and Square (SQ).

Who are Inovalon's key executives?

Inovalon's management team includes the following people:
  • Keith R. Dunleavy, CEO & Chairman (Age 50)
  • Mr. Robert A. Wychulis, Pres (Age 64)
  • Mr. John Michael Burgin, Chief Product Officer (Age 45)
  • Mr. Jonathan R. Boldt, Chief Financial Officer (Age 34)
  • Mr. Jason B. Capitel, Chief Operating Officer (Age 47)

When did Inovalon IPO?

(INOV) raised $500 million in an initial public offering on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

What is Inovalon's stock symbol?

Inovalon trades on the NASDAQ under the ticker symbol "INOV."

Who are Inovalon's major shareholders?

Inovalon's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (3.83%), Loomis Sayles & Co. L P (1.20%), Riverbridge Partners LLC (1.00%), State Street Corp (0.96%), Bernzott Capital Advisors (0.93%) and Geode Capital Management LLC (0.76%). Company insiders that own Inovalon stock include Jason Capitel, Keith R Dunleavy, Lee D Roberts and Robert A Wychulis. View institutional ownership trends for Inovalon.

Which institutional investors are selling Inovalon stock?

INOV stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., UBS Group AG, WINTON GROUP Ltd, Morgan Stanley, First Trust Advisors LP, Cowen Prime Services LLC, Bernzott Capital Advisors, and Deutsche Bank AG. View insider buying and selling activity for Inovalon.

Which institutional investors are buying Inovalon stock?

INOV stock was bought by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Invesco Ltd., Loomis Sayles & Co. L P, Federated Hermes Inc., Hillsdale Investment Management Inc., Mackay Shields LLC, Geode Capital Management LLC, and King Luther Capital Management Corp. Company insiders that have bought Inovalon stock in the last two years include Jason Capitel, Keith R Dunleavy, and Lee D Roberts. View insider buying and selling activity for Inovalon.

How do I buy shares of Inovalon?

Shares of INOV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Inovalon's stock price today?

One share of INOV stock can currently be purchased for approximately $18.90.

How big of a company is Inovalon?

Inovalon has a market capitalization of $2.94 billion and generates $642.41 million in revenue each year. The technology company earns $7.78 million in net income (profit) each year or $0.41 on an earnings per share basis. Inovalon employs 2,662 workers across the globe.

What is Inovalon's official website?

The official website for Inovalon is www.inovalon.com.

How can I contact Inovalon?

Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The technology company can be reached via phone at 301-809-4000 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.